- Home
- VERU vs IAE Comparison
VERU vs IAE Comparison
Compare VERU & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- IAE
- Stock Information
- Founded
- VERU 1971
- IAE 2007
- Country
- VERU United States
- IAE United States
- Employees
- VERU N/A
- IAE N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- VERU Health Care
- IAE Finance
- Exchange
- VERU Nasdaq
- IAE Nasdaq
- Market Cap
- VERU 76.9M
- IAE 65.2M
- IPO Year
- VERU 1990
- IAE N/A
- Fundamental
- Price
- VERU $0.54
- IAE $6.12
- Analyst Decision
- VERU Strong Buy
- IAE
- Analyst Count
- VERU 3
- IAE 0
- Target Price
- VERU $4.33
- IAE N/A
- AVG Volume (30 Days)
- VERU 2.0M
- IAE 46.3K
- Earning Date
- VERU 05-07-2025
- IAE 01-01-0001
- Dividend Yield
- VERU N/A
- IAE 10.21%
- EPS Growth
- VERU N/A
- IAE N/A
- EPS
- VERU N/A
- IAE N/A
- Revenue
- VERU $16,886,419.00
- IAE N/A
- Revenue This Year
- VERU N/A
- IAE N/A
- Revenue Next Year
- VERU N/A
- IAE N/A
- P/E Ratio
- VERU N/A
- IAE N/A
- Revenue Growth
- VERU 22.46
- IAE N/A
- 52 Week Low
- VERU $0.45
- IAE $5.31
- 52 Week High
- VERU $1.75
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- VERU 49.37
- IAE 56.14
- Support Level
- VERU $0.51
- IAE $5.79
- Resistance Level
- VERU $0.56
- IAE $5.93
- Average True Range (ATR)
- VERU 0.04
- IAE 0.13
- MACD
- VERU 0.00
- IAE 0.05
- Stochastic Oscillator
- VERU 38.00
- IAE 100.00
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.